Atrial Fibrillation Surgery Market Worth $1.73 Billion by 2020
PUNE, India, December 10, 2015 /PRNewswire/ --
According to a new market research report "Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020", published by MarketsandMarkets, the global market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020.
Browse 18 market data tables and 73 Slides and in-depth TOC on "Atrial Fibrillation Surgery Market"
http://www.marketsandmarkets.com/Market-Reports/atrial-fibrillation-surgery-market-8998731.html
Early buyers will receive 10% customization on this report.
The report provides a detailed overview of the major drivers, restraints and opportunities impacting the Atrial Fibrillation Surgery Market along with estimates of revenue and competitive landscape. The types of atrial fibrillation ablation procedures within the scope of the study include catheter ablation and surgical ablation. The global atrial fibrillation surgery procedures market is expected to grow at a CAGR of 11.9% during the forecast period.
The Atrial Fibrillation Surgery Market has immense growth potential from 2015 to 2020. The factors propelling growth in this market include increasing number of people suffering from atrial fibrillation and favorable regulations.
About 4.4% people out of diagnosed atrial fibrillation population are treated using ablation technology in the U.S., Europe, and Japan combined. The atrial fibrillation population treated with ablation is expected to grow with a double digit rate in these regions. The increasing prevalence of atrial fibrillation and advancement in the ablation technologies drive the use of ablation products in the treatment of atrial fibrillation.
The European Society of Cardiology guidelines recommend use of surgical and catheter ablation procedures for the treatment of atrial fibrillation, if anti-arrhythmic drug therapy results are inadequate. Further, guidelines recommend using surgical ablation for the treatment of patients failing catheter ablation.
This market is segmented, on the basis of surgical procedures, into catheter ablation and surgical ablation. Catheter ablation procedures hold the maximum share in this market and are expected to grow with the highest CAGR during forecast period of 2015 to 2020.
Ask For PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=8998731
The geographical segmentation in the Atrial Fibrillation Surgery Market includes North America, Europe, Asia-Pacific and RoW. North America holds the largest share in this market, both in terms of number of procedures and revenue. However, Asia-Pacific is expected to witness the highest growth rate owing to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India.
The major players in Atrial Fibrillation Surgery Market include Biosense Webster, Inc., St. Jude Medical, Inc., Medtronic, Inc., Boston Scientific Corporation, Articure, Inc., Cardiofocus, Inc., nContact, Inc., Cardima, Inc. and Biotronik SE & Co.
Browse Related Reports:
Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave), Application (General & Cosmetic Surgery, Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to 2019.
http://www.marketsandmarkets.com/Market-Reports/ablation-devices-market-791.html
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018.
About MarketsandMarkets:
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets
Share this article